Abiomed - Xconomy

by in

Entry	Author	Date	Location
Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)	Luke Timmerman	05/13/13	National
The Boston Biotech Survival Index: Big Fish Still Swimming, Minnows Getting Eaten	Luke Timmerman	10/08/09	Boston
Biotech Survival Index 2: Boston Life Sciences Companies Squirrel Away More Cash for Long Winter	Luke Timmerman	03/17/09	Boston
Biotech Survival Index: Boston Life Sciences Companies Brace for Long, Hard Winter	Luke Timmerman	11/25/08	Boston
ProteoStasis Takes Off From $45 Launch Pad, BitWave Receives $10M Transmission, GameLogic Reckons $8M Will Do, & More Deals News	Rebecca Zacks	08/25/08	Boston
Dyax and Vertex Drugs Move Toward Market, Taligen Moves to MA, Covidien Moves Into Venture Territory, & More Life Sciences News	Rebecca Zacks	08/20/08	Boston
Abiomed To Sell 2.4 Million Shares of Common Stock	Luke Timmerman	08/19/08	Boston
Vertex Cashes Out HIV Drugs, FDA Smiles on Infinity and Frowns on Indevus, Alnylam Makes Cross-Border Investment, & More Life Sciences News	Rebecca Zacks	06/05/08	Boston
Concert Strikes a Chord With Investors, Abiomed Scores a Win with Medicare, Epix Snags $7.5M from GSK, & More Life Sciences News	Rebecca Zacks	05/07/08	Boston
Medicare Will Cover Abiomed Heart	Wade Roush	05/02/08	Boston
Artificial Heart Finally Ready for Market? Abiomed’s Potential “Billion-Dollar Monopoly”	Rebecca Zacks	01/23/08	Boston
Abiomed Device Approved	Rebecca Zacks	12/19/07	Boston
Page 1 of 1

Xconomy National